The Partnership for Safe Medicines India is a group of organizations and individuals that have policies, procedures, or programs to protect consumers from spurious or contraband medicines. For more information, please visit jagograhakjago.com
   India International Medical Equipment Expo - Delhi 1st Nov'2011
|
 Subcommittes of DCC set up for more regulatory effectiveness:
The Drugs and Cosmetics Act (D&C Act) and Rules is to be amended so as to make it a more effective regulatory instrument. To that end, a sub committee of the Drugs Consultative Committee or DCC was set up by the government of a year ago. Dr Hemant G Koshia, commissioner, Gujarat Food & Drugs Control Administration (FDCA), who is a member of this sub-committee, reports that it has had consultations with various regulatory authorities from across the country. The sub committee’s conclusions will now be intimated to the DCC, which will in turn forward these to the Drugs Technical Advisory Board (DTAB) for final approval, Dr. Koshia said. Once the DTAB gives its stamp of approval, the changes in the Act will be notified in the DTAB’s official gazette, and an amended act will come into force.
Source: Pharmabiz
|
 |
|
jagograhakjago.com; jagograhakjago.com; Consumer Conexion